$ACGL

ACGL Maintained by Mizuho -- Price Target Lowered to $100

Mizuho maintained a Neutral rating on Arch Capital Group (ACGL) but lowered its price target to $100 from $104. ACGL's stock is currently trading at $97.61, with a GF Value™ of $107.74, suggesting it is undervalued by 9.4%. The company has a GF Score™ of 85/100, indicating strong performance in growth and valuation, but weak momentum. Insider activity shows significant selling, with $1.09M in sales over the last three months.

Original reporting
Published Sep 16, 2026, 3:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 9:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ACGL
Bearish
medium confidence
Mentioned
$ACGL
Relevance
4/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$ACGLBearishLow
01

Why it matters

Analyst rating change provides a modest bearish signal, but valuation metrics suggest upside potential.

02

Market read

The rating update offers a slight bearish bias for ACGL, but broader sector fundamentals remain strong.

03

What to watch

Strong growth and valuation scores could offset the neutral rating.

Relevance 4/10Novelty 4/10Timing: rating change reported on Oct 3, 2023

Background

Arch Capital Group operates in insurance and reinsurance, with a market cap of ~$33B.

Company-level read

Ticker impact

$ACGLBearishMedium confidence
Context

Mizuho lowered ACGL's price target to $100 and maintained a Neutral rating.

Expected impact

Potential short-term downside of 2‑3% as investors reassess valuation.

Evidence & confidence

Rating change is a fresh analyst opinion but lacks a catalyst; impact likely limited.

Market effects

May slightly affect sentiment in the insurance sector.

Limited to U.S. market participants.

Low

Counterpoint

Despite the downgrade, the stock appears undervalued per GF Value metrics.

Key entities

  • Mizuho

    Provided the Neutral rating and $100 price target.

Related articles

$ACGLMed

Arch Capital Group Ltd. Q2 2026 Earnings Call Summary

Strategic Performance and Market Dynamics Management characterizes the current environment as the early stages of a softening market, driven by an influx of capacity in property and short-tail lines. Insurance segment performance was impacted by catastrophe losses from the Iran conflict, though underlying results remain strong with a 91.6% current accident year ex-cat combined ratio.

$ACGLMed

Arch Capital Q2 underwriting income falls 20% on cat losses

Arch Capital Group reported Q2 2026 underwriting income down 19.7% to $657 million, with the consolidated combined ratio at 83.5% as catastrophe losses lifted the loss ratio to 55.1%. Net premiums written fell 6.9% to $4.05 billion. Net income to common shareholders was $1.05 billion, or $3.00 per diluted share. The company repurchased $1.2 billion of shares.

$ACGLMed

Arch posts $1b profit despite $200m catastrophe hit

Arch Capital Group reported Q2 net income of $1.047 billion ($3.00 per diluted share), down 14.6% YoY. Underwriting income fell 19.7% to $657 million as the combined ratio rose to 83.5%. The company absorbed $201 million of catastrophe losses and repurchased $1.2 billion of shares. Gross premiums written slipped to $6.13 billion.

$ACGLMed

ARCH CAPITAL GROUP LTD. (ACGL): Results of Operations and Financial Condition

ARCH CAPITAL GROUP LTD. (ACGL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 ex-992supplement63026.htm EX-99.2 Document EXHIBIT 99.2 Arch Capital Group Ltd. Waterloo House, Ground Floor 100 Pitts Bay Road Pembroke HM 08 Bermuda Financial Supplement June 30, 2026 The following financial supplement is provided to assist in your understanding of Ar